CClinicalTrials.gg
CompletedNCT03305484SCOREUpdated Sep 18, 2019

Soft Contacts Observation of Risk and Education (SCORE)

An observational study in Contact Lens Complication, Contact Lens Acute Red Eye and Contact Lens Related Corneal Infiltrate (Disorder), sponsored by Southern California College of Optometry at Marshall B. Ketchum University. Completed at 5 sites in 2 countries. Open to participants aged 18 Years to 39 Years. Per ClinicalTrials.gov, last updated 2019-09-18.

Sponsored by Southern California College of Optometry at Marshall B. Ketchum University · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
171
Ages
18 Years to 39 Years
Sex
All
01

Study summary

Specific Aims

  1. Develop risk assessment scores for SCL wearers
  2. Test the scoring algorithm in SCL wearers who present with adverse events
  3. Explore targeted patient education to reduce risk behaviors associated with SCL wear.
Read the detailed description

This will be a multi-center, case-control prospective study. Subjects will be enrolled at five geographically diverse locations across North America. The intent is to enroll cases with new (untreated) red eyes and controls that are representative of the contact lens wearing population and test the new scoring algorithm on this population.

A total of 232 participants are expected to complete the study (116 case-control sets). Enrollment will be competitive. After consent, subjects will complete the Contact Lens Risk Survey (CLRS) online at www.claystudy.org. Data related to symptoms, medical history and anterior segment evaluation will be collected. Subjects will be treated as usual and customary by the investigator. No intervention of treatment in this study. Subjects will be asked to repeat the CLRS at one and six months post initial visit.

Initial factor analysis from the previous CLRS data were used to develop and test the CLRS algorithm. Five sub-scales were identified in the areas of contact lens care, contact lens dependence, hygiene, living arrangements and wellness. Assuming a 10% missing data rate, a total of 58 SCL wearers with "serious and significant" red eye events will allow for detection of 0.4 or larger effect size.

There are multiple steps to "compliant wear" of contact lenses and while many patients do many of the correct wear behaviors, it's not realistic for practitioners to re-educate all wearers on all of the steps necessary to successfully wear SCLs. The CLRS allows patients to quickly report their specific wear behaviors and then receive only the targeted information on which behaviors they are doing that puts them at higher risk. A previous CLAY study demonstrated good repeatability of the CLRS survey one week after initial fielding.

02

Conditions studied

  • Contact Lens Complication
  • Contact Lens Acute Red Eye
  • Contact Lens Related Corneal Infiltrate (Disorder)
  • Contact Lens-Induced Corneal Fluorescein Staining

Keywords

  • contact lenses
  • red eye
  • corneal infiltrate
03

Who can participate

Ages eligible
18 Years to 39 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

A total of 232 participants are expected to complete the study (116 case-control sets). Enrollment will be competitive; with each of five geographic locations in the United States and Canada enrolling approximately 24, but no more than 29 case-control sets until the total sample size of is achieved.

Inclusion criteria

  • CASES

    • Current SCL wear (as defined by having worn lenses in previous week) without restriction on lens material, design, indication, wearing schedule or lens power
    • 18 - 39 years of age
    • New (untreated) symptomatic red eye CONTROLS
    • Current SCL wear (as defined by having worn lenses in previous week) without restriction on lens material, design, indication, wearing schedule or lens power
    • 18 - 39 years of age and gender and age-matched (± 3 years) to Case
    • Have not had an eye care examination within the past three months

Exclusion criteria

Exclusion Criteria:

  • CASES

    • Faculty, staff or student at an optometry college or school
    • Family or household member of an eye care provider, ophthalmic technician, ophthalmology or optometry residents or optometry students
    • Pregnancy (by self-report)
    • Currently enrolled in another eye/vision clinical trial
    • Previous participant in a CLAY study
    • Wearing SCL in conjunction with gas permeable (GP) lenses (i.e., piggyback design, hybrid lens.) CONTROLS
    • Same exclusion criteria as cases
04

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
171 participants (actual)
Patient registry
No

Groups and cohorts

  • Symptomatic Contact Lens Wearers

    Contact lens wearers who present to the eye care practitioner's office with a symptomatic red eye

    Other: No intervention

Interventions

  • OtherNo intervention

    No intervention, observation only

    Also known as: No intervention, observation only

05

What researchers measure

Primary outcomes

  1. Validation of the Contact Lens Risk Survey (CLRS)

    This study will further validate the CORS and facilitate its translation into clinical practice. A scoring algorithm will be developed.

    Time frame: twelve months

  2. Targeted Patient Education

    Scripted patient education will be generated based on the results of the Contact Lens Risk Survey (CLRS) to determine if changes in behavior at the one and six month time point

    Time frame: twelve months

06

Study locations

5 sites
  • Marshall B. Ketchum University
    Fullerton, California 92831, United States
  • Nova Southeastern University College of Optometry
    Fort Lauderdale, Florida 33314, United States
  • The Ohio State, College of Optometry
    Columbus, Ohio 43210, United States
  • University of Houston, College of Optometry
    Houston, Texas 77204, United States
  • University of Waterloo, Optometry and Vision Science
    Waterloo, Ontario N2L 3G1, Canada
07

References and documents

Individual participant data

Plan to share: No — No plans to share IPD

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03305484
Lead sponsor
Southern California College of Optometry at Marshall B. Ketchum University
Collaborators
University of Houston, New England College of Optometry, Ohio State University, University of Waterloo, Pacific University, Nova Southeastern University, Alcon Research
Responsible party
Dawn Lam, MSc, OD (Associate Professor, Southern California College of Optometry at Marshall B. Ketchum University) — Principal investigator
First posted
Oct 10, 2017
Start date
Dec 30, 2017
Primary completion
Oct 16, 2018
Completion
Apr 16, 2019
Last update
Sep 18, 2019

Study contacts

Dawn Lam
principal investigator · Marshall B. Ketchum University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion